X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-19 | ACRS | Mehra Anand | Dir | P - Purchase | $2.25 | +666,666 | 710,030 | >999% | +$1,499,999 | ||||||
| M | 2024-08-02 | ACRS | Leonard Braden Michael | 10% | P - Purchase | $1.27 | +373,569 | 28,293,975 | +1% | +$472,757 | |||||
| M | 2024-07-30 | ACRS | Leonard Braden Michael | 10% | P - Purchase | $1.31 | +273,730 | 27,652,842 | +1% | +$359,010 | |||||
| M | 2024-07-18 | ACRS | Leonard Braden Michael | 10% | P - Purchase | $1.30 | +154,722 | 27,180,977 | +1% | +$201,808 | |||||
| M | 2024-07-02 | ACRS | Leonard Braden Michael | 10% | P - Purchase | $1.15 | +352,397 | 26,629,633 | +1% | +$405,894 | |||||
| M | 2024-06-27 | ACRS | Leonard Braden Michael | 10% | P - Purchase | $1.13 | +1,543,434 | 24,882,706 | +7% | +$1,742,075 | |||||
| M | 2024-06-14 | ACRS | Leonard Braden Michael | 10% | P - Purchase | $1.15 | +545,000 | 22,904,268 | +2% | +$628,206 | |||||
| M | 2024-06-11 | ACRS | Leonard Braden Michael | 10% | P - Purchase | $1.11 | +1,611,200 | 11,007,134 | +17% | +$1,781,897 | |||||
| M | 2024-03-01 | ACRS | Powell Andrew Kenneth William | Dir | P - Purchase | $1.24 | +14,500 | 28,863 | +101% | +$17,955 | |||||
2023-10-23 | ACRS | Monahan Joseph | Chief Scientific Officer | S - Sale | $5.08 | -6,000 | 129,917 | -4% | -$30,460 | ||||||
2023-09-06 | ACRS | Balthaser Kevin | CFO | P - Purchase | $7.90 | +9,490 | 15,461 | +159% | +$74,971 | ||||||
2023-08-28 | ACRS | Loerop James | Chief Business Officer | P - Purchase | $6.80 | +14,705 | 21,688 | +211% | +$99,959 | ||||||
2023-08-21 | ACRS | Monahan Joseph | Chief Scientific Officer | S - Sale | $7.32 | -6,000 | 135,917 | -4% | -$43,895 | ||||||
2023-06-20 | ACRS | Monahan Joseph | Chief Scientific Officer | S - Sale | $10.28 | -6,000 | 141,917 | -4% | -$61,663 | ||||||
2023-03-17 | ACRS | Manion Douglas J. | Pres, CEO | P - Purchase | $7.86 | +6,300 | 12,800 | +97% | +$49,532 | ||||||
2023-03-09 | ACRS | Manion Douglas J. | Pres, CEO | P - Purchase | $7.74 | +6,500 | 6,500 | New | +$50,278 | ||||||
| DM | 2023-03-02 | ACRS | Walker Neal | Dir | S - Sale+OE | $12.50 | -59,240 | 1,273,202 | -4% | -$740,658 | |||||
| DM | 2023-03-02 | ACRS | Monahan Joseph | Chief Scientific Officer | S - Sale+OE | $12.51 | -30,837 | 147,917 | -17% | -$385,639 | |||||
| DM | 2023-03-02 | ACRS | Balthaser Kevin | CFO | S - Sale+OE | $12.45 | -1,894 | 5,256 | -26% | -$23,579 | |||||
2023-02-15 | ACRS | Monahan Joseph | Chief Scientific Officer | S - Sale | $13.06 | -5,000 | 91,579 | -5% | -$65,311 | ||||||
2023-02-08 | ACRS | Loerop James | Chief Business Officer | S - Sale | $13.89 | -4,267 | 6,983 | -38% | -$59,272 | ||||||
| M | 2023-02-01 | ACRS | Walker Neal | Dir | S - Sale | $16.66 | -30,000 | 1,175,763 | -2% | -$499,923 | |||||
| M | 2023-01-03 | ACRS | Walker Neal | Dir | S - Sale | $15.11 | -40,000 | 1,205,763 | -3% | -$604,556 | |||||
2022-12-15 | ACRS | Monahan Joseph | Chief Scientific Officer | S - Sale | $15.88 | -5,000 | 96,579 | -5% | -$79,412 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |